We are thrilled to share that Sparta Biodiscovery has received an investment for up to 3.5 million £ from industry partner Sartorius. This funding will support the deployment of SPARTA® in a range of commercial settings.

SPARTA® will aid the development of the next generation of pharmaceuticals, providing for accelerated and robust nanoformulationanalysis across all sectors of life sciences.

Read more about SPARTA Biodiscovery and the technology behind it.